Aou Federico Ii - Napoli - Uoc Ematologia

Napoli, Italy
School in Naples
Via del Sole, 10, 80138 Napoli NA

About Aou Federico Ii - Napoli - Uoc Ematologia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gruppo Italiano Malattie EMatologiche dell'Adulto
7
Alexion
2
Total Rows: 2

Clinical Trials at Aou Federico Ii - Napoli - Uoc Ematologia


During the past decade, Aou Federico Ii - Napoli - Uoc Ematologia conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110011222211001100000000Started TrialsCompleted Trails2016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab
2004-12-01
2006-11-01
Completed
85
Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)
2005-05-01
2008-10-01
Completed
187
Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib
2016-06-23
2023-02-01
Active, not recruiting
16
Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)
2019-03-19
2020-06-05
Terminated
21
Investigation on a Dynamic Cohort of Italian Patients With Active ITP
2018-10-15
2023-07-01
Recruiting
861
Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study
2019-02-06
2020-10-28
Completed
104
The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide
2020-07-07
2024-07-01
Recruiting
180
Gemtuzumab Chemotherapy MRD Levels; Glasdegib Post-transplant, Adult Untreated, de Novo, Fav Interm Risk AML
2020-09-24
2027-04-01
Recruiting
414

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Aou Federico Ii - Napoli - Uoc Ematologia" #1 collaborator was "ERIC Group" with 1 trials as a collaborator and "Hematology Project Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGruppo Italiano MalattieEMatologichedell'Adulto: 7Gruppo Italiano MalattieEMatologichedell'Adulto: 7Alexion: 2Alexion: 2

Created with Highcharts 11.1.0Top CollaboratorsERIC Group: 1ERIC Group: 1Hematology ProjectFoundation: 1Hematology ProjectFoundation: 1

Clinical Trials Conditions at Aou Federico Ii - Napoli - Uoc Ematologia


According to Clinical.Site data, the most researched conditions in "Aou Federico Ii - Napoli - Uoc Ematologia" are "Acute Myeloid Leukemia" (2 trials), "Acute Lymphoblastic Leukemia, in Relapse" (1 trials), "Adults" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Chronic Lymphoid Leukemia" (1 trials). Many other conditions were trialed in "Aou Federico Ii - Napoli - Uoc Ematologia" in a lesser frequency.

Clinical Trials Intervention Types at Aou Federico Ii - Napoli - Uoc Ematologia


Most popular intervention types in "Aou Federico Ii - Napoli - Uoc Ematologia" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ponatinib" (2 trials), "eculizumab" (2 trials), "Chemotherapy" (1 trials), "Gemtuzumab Ozogamicin" (1 trials) and "Glasdegib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Aou Federico Ii - Napoli - Uoc Ematologia


The vast majority of trials in "Aou Federico Ii - Napoli - Uoc Ematologia" are 9 trials for "All" genders.

Clinical Trials Status at Aou Federico Ii - Napoli - Uoc Ematologia


Currently, there are NaN active trials in "Aou Federico Ii - Napoli - Uoc Ematologia". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Aou Federico Ii - Napoli - Uoc Ematologia, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Aou Federico Ii - Napoli - Uoc Ematologia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 3Phase 2: 3Phase 3: 3Phase 3: 3

Created with Highcharts 11.1.0Trials StatusRecruiting: 4Recruiting: 4Completed: 3Completed: 3Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1